Form 8-K - Current report:
SEC Accession No. 0001104659-24-062263
Filing Date
2024-05-16
Accepted
2024-05-16 07:16:09
Documents
18
Period of Report
2024-05-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414628d1_8k.htm   iXBRL 8-K 30223
2 EXHIBIT 3.1 tm2414628d1_ex3-1.htm EX-3.1 2663
3 EXHIBIT 99.1 tm2414628d1_ex99-1.htm EX-99.1 15075
7 GRAPHIC tm2414628d1_ex3-1img001.jpg GRAPHIC 115226
8 GRAPHIC tm2414628d1_ex3-1img002.jpg GRAPHIC 138756
9 GRAPHIC tm2414628d1_ex99-1img001.jpg GRAPHIC 4267
  Complete submission text file 0001104659-24-062263.txt   586005

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20240515.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20240515_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20240515_pre.xml EX-101.PRE 22367
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2414628d1_8k_htm.xml XML 3806
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 24953554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)